113 related articles for article (PubMed ID: 2692058)
21. Local x-ray irradiation of the rat head (30 Gy). III. Behaviour and effect of pyritinol after 24, 72 and 120 hours.
Tikal K; Jelínek F; Roth Z; Vorreith M
Act Nerv Super (Praha); 1987 Dec; 29(4):295-8. PubMed ID: 2964162
[No Abstract] [Full Text] [Related]
22. Effect of pyritinol on EEG and SSEP in comatose patients in the acute phase of intensive care therapy.
von Wild K; Simons P; Schoeppner H
Pharmacopsychiatry; 1992 May; 25(3):157-65. PubMed ID: 1635936
[TBL] [Abstract][Full Text] [Related]
23. Neurochemical studies on the mechanism of action of pyritinol.
Greiner HE; Haase AF; Seyfried CA
Pharmacopsychiatry; 1988 Aug; 21 Suppl 1():26-32. PubMed ID: 2905813
[TBL] [Abstract][Full Text] [Related]
24. Pyritinol and the enzymes of gamma-aminobutyric acid (GABA) synthesis and degradation.
Turský T
Physiol Bohemoslov; 1988; 37(2):135-43. PubMed ID: 2975003
[TBL] [Abstract][Full Text] [Related]
25. Effects of pyritinol on maze escape learning and memory.
Hassmannová J; Myslivecek J; Stastná D; Stoilov S
Act Nerv Super (Praha); 1978 Dec; 20(4):262-4. PubMed ID: 735727
[No Abstract] [Full Text] [Related]
26. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
27. N1--P2 component of the auditory evoked potential during alcohol intoxication and interaction of pyrithioxine in healthy adults.
Krogh HJ; Khan MA; Fosvig L; Jensen K; Kellerup P
Electroencephalogr Clin Neurophysiol; 1978 Jan; 44(1):1-7. PubMed ID: 74317
[TBL] [Abstract][Full Text] [Related]
28. On the mechanism of action of Encephabol.
Martin KJ
J Int Med Res; 1983; 11(2):55-65. PubMed ID: 6189751
[No Abstract] [Full Text] [Related]
29. Effect sizes of P300 in schizophrenics.
Ebmeier K
Biol Psychiatry; 1991 Jun; 29(11):1159-60. PubMed ID: 1873378
[No Abstract] [Full Text] [Related]
30. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
[TBL] [Abstract][Full Text] [Related]
31. Difference in learning and retention by albino-Swiss mice. Part 1. Effect of pyritinol.
Valzelli L; Tomasíková
Methods Find Exp Clin Pharmacol; 1985 Oct; 7(10):515-7. PubMed ID: 4079584
[TBL] [Abstract][Full Text] [Related]
32. Effects of nootropic drugs on brain cholinergic and dopaminergic transmission.
Pavlík A; Benesová O; Dlohozková N
Act Nerv Super (Praha); 1987 Mar; 29(1):62-5. PubMed ID: 3035858
[TBL] [Abstract][Full Text] [Related]
33. Effect of pyritinol-GCl on blood flow and oxidative metabolism of the brain in patients with dementia.
Hoyer S; Oesterreich K; Stoll KD
Arzneimittelforschung; 1977; 27(3):671-4. PubMed ID: 577444
[TBL] [Abstract][Full Text] [Related]
34. [Our experience with pyritinol in patient with brain concussion].
Bystrický Z; Zouhar A; Janík B
Med Welt; 1977 Apr; 28(13):643-6. PubMed ID: 323638
[No Abstract] [Full Text] [Related]
35. Psychotropic drug profiles: comparisons by topographic maps of absolute power.
Coppola R; Herrmann WM
Neuropsychobiology; 1987; 18(2):97-104. PubMed ID: 3330184
[TBL] [Abstract][Full Text] [Related]
36. [Clinical experience with Encephabol (author's transl)].
Glatzel J
Med Klin; 1976 Nov; 71(45):1958-61. PubMed ID: 792665
[TBL] [Abstract][Full Text] [Related]
37. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
[TBL] [Abstract][Full Text] [Related]
38. [EEG monitoring in observation and control of sedation on the intensive care unit].
Pichlmayr I
Klin Anasthesiol Intensivther; 1994; 46():253-61. PubMed ID: 8065099
[No Abstract] [Full Text] [Related]
39. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
[TBL] [Abstract][Full Text] [Related]
40. Pyritinol inhibition of the GABA and benzodiazepine receptor.
Turský T
Physiol Bohemoslov; 1988; 37(5):417-26. PubMed ID: 2851848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
